A Promising Therapeutic Approach for Multiple Sclerosis: Recombinant T-Cell Receptor Ligands Modulate Experimental Autoimmune Encephalomyelitis by Reducing Interleukin-17 Production and Inhibiting Migration of Encephalitogenic Cells into the CNS

Eitemau Tebyg

• IL-13-Mediated Gender Difference in Susceptibility to Autoimmune Encephalomyelitis
  gan: Sinha, Sushmita, et al.
  Cyhoeddwyd: (2008)
• Cytokine Switch and Bystander Suppression of Autoimmune Responses to Multiple Antigens in Experimental Autoimmune Encephalomyelitis by a Single Recombinant T-Cell Receptor Ligand
  gan: Sinha, Sushmita, et al.
  Cyhoeddwyd: (2009)
• RTL551 treatment of EAE reduces CD226 and T-bet+ CD4 T cells in periphery and prevents infiltration of T-bet+ IL-17, IFN-γ producing T cells into CNS.
  gan: Sushmita Sinha, et al.
  Cyhoeddwyd: (2011-01-01)
• RTL551 Treatment of EAE Reduces CD226 and T-bet+ CD4 T Cells in Periphery and Prevents Infiltration of T-bet+ IL-17, IFN-γ Producing T Cells into CNS
  gan: Sinha, Sushmita, et al.
  Cyhoeddwyd: (2011)
• RTL551 treatment of EAE reduces CD226 and T-bet+ CD4 T cells in periphery and prevents infiltration of T-bet+ IL-17, IFN-γ producing T cells into CNS.
  gan: Sushmita Sinha, et al.
  Cyhoeddwyd: (2011-01-01)